Health News

Thyroid Cancer on the Rise in Pennsylvania
Thyroid cancer rates are increasing in the US. But one state may be contributing to the rising rate more than the others.
FDA Advises Consumers Not to Use Weight Loss Supplement
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Best Line Suplemento Alimenticio Capsules, a product promoted and sold for weight loss on various websites and in some retail stores.
Mezo Contains Hidden Drug Ingredient
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Mezo, a product promoted and sold for weight loss on various websites and in some retail stores.
LX1 Contains Hidden Drug Ingredient
The Food and Drug Administration (FDA) is advising consumers not to purchase or use LX1, a product promoted and sold for weight loss on various websites, including Dr. Skin Secretsdisclaimer icon, and possibly in some retail stores.
New Breast Cancer Vaccine Tested
Efforts to fight cancer include both treatment and prevention. And researchers recently tested a vaccine to prevent breast cancer recurrence.
More Exercise May Improve Boys' School Performance
Young boys who bike or walk to school or play sports benefit in many ways. Not only are they more fit, but they may even do better in school, new research suggests.
Sleep Disorders May Go Undiagnosed in MS Patients
One of the most common symptoms of multiple sclerosis (MS) is fatigue. And new research suggests fatigue may be common among MS patients because they have undiagnosed sleep disorders.
Health Officials Struggle to Respond to Ebola Outbreak
The Ebola outbreak in West Africa isn't showing many signs of slowing. According to the head of the World Health Organization (WHO), the number of new Ebola cases is climbing at such a rate that health authorities are struggling to manage them.
FDA: Liraglutide Safe for Obesity Treatment
On Sept. 10, the US Food and Drug Administration (FDA) approved a new weight-loss medicine called Contrave. Today, an FDA panel voted to approve another weight-loss medicine.
Hospira Issues Recall of Anticoagulant Used in Catheterization
Hospira, Inc. (NYSE: HSP), announced today it is initiating a voluntary nationwide user-level recall of one lot of Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500 mL, NDC 0409-7620-03 Lot 41-046-JT with expiration date of 01NOV 2015.
<< first361362363364365366367368369last >>

REFINE